发明授权
EP1436756B1 POLYMORPHIC MARKER THAT CAN BE USED TO ASSESS THE EFFICACY OF INTERFERON THERAPY
有权
多晶型标记，用来保证干扰素治疗的有效性DETERMINE
- 专利标题： POLYMORPHIC MARKER THAT CAN BE USED TO ASSESS THE EFFICACY OF INTERFERON THERAPY
- 专利标题（中）： 多晶型标记，用来保证干扰素治疗的有效性DETERMINE
-
申请号： EP02763042.5申请日： 2002-09-20
-
公开(公告)号： EP1436756B1公开(公告)日： 2009-01-07
- 发明人: MATSUYAMA, Noriko , SUGIMOTO, Masanobu , HASHIMOTO, Michie , MISHIRO, Shunji
- 申请人： KABUSHIKI KAISHA TOSHIBA
- 申请人地址： 1-1, Shibaura 1-chome, Minato-ku Tokyo 105-8001 JP
- 专利权人： KABUSHIKI KAISHA TOSHIBA
- 当前专利权人： KABUSHIKI KAISHA TOSHIBA
- 当前专利权人地址： 1-1, Shibaura 1-chome, Minato-ku Tokyo 105-8001 JP
- 代理机构： Andrews, Timothy Stephen
- 优先权： JP2001318472 20011016; JP2002143004 20020517
- 国际公布： WO2003033738 20030424
- 主分类号： G06F19/00
- IPC分类号： G06F19/00 ; C12Q1/70
摘要：
The present invention provides a polymorphic marker found in a region of the interferon receptor gene that can be used to assess the efficacy of interferon therapy. Thus, the present invention also relates to methods of assessing the efficacy of interferon therapy in an individual and means for accomplishing such a method.
公开/授权文献
信息查询
